Association of antiPD1 immunotherapy with immunogenic cell death-inducing chemotherapy in a murine model of squamous cell lung cancer

Conclusion: Association of anti-PD1 and cyclophosphamide for the treatment of lung SCC in our model can reduce tumor evolution. A hypothesis for these results is a decrease of T regulator cells in tumors.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Jeanvoine, M., Guisier, F., Bohn, P., Thiberville, L., Salaun, M. Tags: Lung Cancer Source Type: research